Intradermal Delivery for Vaccine Dose Sparing: Overview of Current Issues
Preclinical and clinical data highlight potential benefits from intradermal delivery of reduced doses of vaccines, possibly using novel delivery devices. This article, published in Vaccine, outlines evidence gaps and logistical challenges of this vaccine delivery approach that need to be further researched before the approach can have a lasting positive effect on vaccine-preventable disease.
Author(s): Zehrung D, Jarrahian C, Wales A
Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Zehrung D, Jarrahian C, Wales A. Intradermal Delivery for Vaccine Dose Sparing: Overview of Current Issues. Vaccine. 2013;31(34):3392-3395.